Current Projects:
Amount awarded: €504,000.00
Period: 04/2018 – 03/2022
Science Foundation Ireland Centre grant “FutureNeuro”
Allocated amount to PI: €110,000.00
Period: 09/2017 – 08/2021
- Health Research Board (HRA-POR-2015-1243) “Blood adenosine levels as a novel diagnostic of seizures in humans”
Amount awarded: €310,000.00
Period: 03/2016 – 02/2019
- StAR programme RCSI“Hyperexcitability mediating MicroRNAs as novel diagnostics and therapeutics”
Amount awarded: €150,000.00
Period: 04/2016 – 04/2020
Past Projects:
- SIRG SFI Starting Investigator Research Grant (13/SIRG/2098 ) “Novel treatments and diagnostics for epilepsy via the ATPgated P2X7 receptor”
Amount of award: €519,000.00
- SFI Technology Innovation Development Award (TIDA) “Development of a simple, fast blood test to support seizure diagnosis”
Amount awarded: €90,208.00
Period: 01/2017 – 12/2017
- Enterprise Ireland (EI) ”Interdisciplinary training network on the purinergic P2X7 receptor to control neuroinflammation and hyperexcitability in brain diseases”
Amount awarded: €11,627.00
Period: 10/2015 – 06/2016
- COEN Network of Centres of Excellence in Neurodegeneration “microRNA as novel therapeutic targets and disease biomarkers in Alzheimer’s Disease, Frontotemporal dementia and Amyotrophic lateral sclerosis (NEURO-MIR)”
Amount of award: €248,819.00 (allocatedto PI: €99,000.00)
Period: 11/2013-10/2015
- Enterprise Ireland “P2X7 Receptor as a Target for Therapeutics and Diagnostics in Disorders of the brain”
Amount awarded: €6,600.00
Period: 10/2014 – 07/2015
- HRB Health Research Award POR/2012/56 “A novel treatment for neonatal seizures; pharmacologic targeting of the P2X7 receptor”
Amount of award: €154,710.00
Period: 10/2012 – 09/2015
- HRB Health Research Award POR/2011/41 “The proteasome as a treatment target for preventing seizure-induced neuronal death and epilepsy”
Amount of award: €247,532.00
Period: 10/2011 – 09/2014
- HRB Health Research Award POR/2010/123 “Seizure control in drug-resistant epilepsy by targeting the purinergic P2X7 receptor”.
Amount of award: €230,369.00
Period: 10/2010 – 09/2013
- HRB Postdoctoral fellowship PD/2009/31 Type: Postdoctoral fellowship “Glycogen synthase kinase -3 as a therapeutic target in seizure-induced neuronal death and epileptogenesis”.
Amount of award: €215, 385.00
Period: 09/2009 – 08/2012
- IRCSET Postdoctoral fellowship “PUMA in seizure-induced cell death and epileptogenesis”
Amount of award: €230,369.00
Period: 12/2007 – 09/2009